Chemicals and pharmaceuticals · RPHM

Reneo Pharmaceuticals, Inc.

12 filings mentioning 8 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
8topics disclosed
Chemicals and pharmaceuticalsindustry
CAbased in

Across 12 filings we hold, Reneo Pharmaceuticals, Inc. has written down 8 of the topics we track. That places it 184 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

RPHM Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something Reneo Pharmaceuticals, Inc. has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO 27001:202242
ISO 37001:201639
ASD Strategies to Mitigate Cyber Security Incidents29
GDPR26
ISO 3700126
ISO/IEC 27701:201921
Code of Conduct on Data Protection for Research (GDPR Article 40)12
CIRCIA (Cyber Incident Reporting for Critical Infrastructure Act)12
COSO Internal Control9

10 frameworks, 294 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Ransomware18
Cross Border Data Transfer14
Data Residency7
Restatement5
Enforcement Action4
Internal Control4
Material Weakness3
Cybersecurity Incident Disclosure2

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Ransomware182026-05-05
Cross Border Data Transfer142024-08-13
Data Residency72022-11-08
Restatement52026-06-04
Enforcement Action42024-10-08
Internal Control42026-03-30
Material Weakness32026-03-30
Cybersecurity Incident Disclosure22026-03-12

When it filed

Filings we hold, by year. Hover a bar for the count.

21
22
23
24
25
26

Recent filings

FiledFormItem
2026-06-048-KDirector or officer departure, Shareholder vote, Financial statements and exhibitsfiling
2026-05-0510-Qfiling
2026-03-308-KEntry into a material agreement, Item 3.02, Director or officer departurefiling
2026-03-1210-Kfiling
2025-11-068-KEntry into a material agreement, Financial statements and exhibitsfiling
2025-08-1210-Qfiling
2025-05-0610-Qfiling
2025-03-1010-Kfiling
2024-11-078-KChange of accountant, Other material event, Financial statements and exhibitsfiling
2024-10-088-KCompletion of an acquisition, Item 3.02, Item 3.03filing
2024-08-1310-Qfiling
2024-05-138-KEntry into a material agreement, Item 3.02, Item 5.01filing

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition